Evaluating the effect of a fish oil supplement on the Omega-3 Index of three professional cyclists competing in the Tour de France: a case study.
Omega-3 index and professional road cycling
Keywords:Elite cycling, Grand tour, Omega-3 Index, fish oil, EPA, DHA
Background: Modifying the Omega-3 Index (O3I) in the elite endurance cyclist is desirable for cardiovascular and anti-inflammatory effects. This case study evaluated the effect of evidence based fish oil supplementation, providing long chain omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on three elite riders taking part in the Tour de France (TdF).
Methods: The O3I of three riders was evaluated using a finger prick blood sample at the start of the season. Riders were then advised to consume daily fish oil supplements (NAMEDsport) according to their initial O3I to achieve >8% membrane EPA+DHA. Follow up blood samples were collected before and after the TdF.
Results: At baseline, the O3I of rider one (R1: 6.23%) and two (R2: 6.77%) were categorised as sub-optimal (<8%) whereas rider three (R3: 9.66%) was >8%. Two daily fish oil capsules (1118 mg EPA/458 mg DHA) increased the O3I to in both R1 (8.40%) and R2 (9.69%) by the start of the TdF and this was maintained upon completion of the race (R1: 8.81%; R2: 9.37%). The O3I of R3 (9.24%) was maintained by consuming one daily fish oil capsule (559 mg EPA/229 mg DHA) in the lead up to the TdF and upon completion their O3I was similar (9.52%) despite increasing their intake to two daily capsules during the TdF.
Conclusion: This case study demonstrates that an elite cyclist, consuming 1-2 daily fish oil capsules, can achieve and maintain a high O3I, in the favour of cardio-protection and anti-inflammation during arduous competition.
How to Cite
Copyright (c) 2021 Journal of Science and Cycling
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors contributing to Journal of Science and Cycling agree to publish their articles under a Creative Commons CC BY-NC-ND license, allowing third parties to copy and redistribute the material in any medium or format, and to remix, transform, and build upon the material, for any purpose, even commercially, under the condition that appropriate credit is given, that a link to the license is provided, and that you indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Authors retain copyright of their work, with first publication rights granted to Cycling Research Center.